home All News open_in_new Full Article

Fears over £160bn blow to London’s stock market as AstraZeneca considers listing move to US

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate


today 16 h. ago attach_file Economics

attach_file Economics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics


ID: 965886163
Add Watch Country

arrow_drop_down